Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.03 -0.18 (-1.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Other Accumulated Expenses (2018 - 2019)

Updated

Arcturus Therapeutics Holdings (ARCT) recorded Other Accumulated Expenses of $560,000 in Q3 2019, down 55.3% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Other Accumulated Expenses (2018 - 2019) Analysis & Trends

At the end of FY2018, Arcturus Therapeutics Holdings reported Other Accumulated Expenses of $674,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Arcturus Therapeutics Holdings 370.35 Mn -443.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 560,000.00
Jun 30, 2019 1.25 Mn
Dec 31, 2018 674,000.00
API Access

Arcturus Therapeutics Holdings Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ARCT&period=max&api_key=YOUR_API_KEY